HeartFlow
Medical AI · Medical Imaging Systems

HeartFlow: Products & infrastructure

HeartFlow has 17 clinical trials on record, 6 under way. It holds 7 FDA 510(k) clearances. HeartFlow paid US doctors and teaching hospitals $2.9M in 2025, and $1.3M for research (CMS Open Payments).

Data updated Nov 22, 2026 · Back to the company report

Products

HeartFlow has 17 clinical trials on record, 6 under way. It holds 7 FDA 510(k) clearances. HeartFlow paid US doctors and teaching hospitals $2.9M in 2025, and $1.3M for research (CMS Open Payments).

17clinical trials
6trials under way
7FDA clearances
$4.2Mpaid to US doctors in 2025
Payments to US doctorsCMS Open Payments - the maker's totals, no recipient
2025
general $2.9M · research $1.3M · 14,410 records
$4.2M
2024
general $1.7M · research $210k · 9,625 records
$1.9M
2023
general $1M · research $549k · 6,067 records
$1.6M
Compensation For Services Other Than Consulting, Including S
a kind of payment, 2025
$1.3M
Food And Beverage
a kind of payment, 2025
$684k
Consulting Fee
a kind of payment, 2025
$554k
Ffrct
a product, 2025
$2.9M
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 9 more records
REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Ar…
under way · 500 participants · CAD - Coronary Artery Disease
Nov 2026
REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Kno…
under way · 350 participants · CAD - Coronary Artery Disease
Oct 2026
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
under way · 5,000 participants · Coronary Artery Disease (CAD)
Mar 2026
Using CTA Measures to Define Cardiac Risk In NFL Alumni
under way · 300 participants · Coronary Artery Disease (CAD); Heart Disease; Coronary Atherosclerosis
Dec 2024
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
under way · 20,000 participants · Coronary Artery Disease
Mar 2024
The COMPLETE Study
under way · 250 participants · as a collaborator · Coronary Artery Disease
Oct 2023
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
stopped or withdrawn · 18 participants · Coronary Artery Disease
Jul 2022
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
completed · 258 participants · Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atheros…
Oct 2021
FDA 510(k) clearancesmedical devices cleared for the US market
HeartFlow Analysis
K250902 · Class 2 · Cardiovascular
Jul 2025
HeartFlow Analysis
K213857 · Class 2 · Cardiovascular
Oct 2022
HeartFlow Analysis
K203329 · Class 2 · Cardiovascular
Jan 2021
HeartFlow FFRct Analysis
K190925 · Class 2 · Cardiovascular
Aug 2019
FFRct
K182035 · Class 2 · Cardiovascular
Dec 2018
FFRct
K161772 · Class 2 · Cardiovascular
Aug 2016
FFRct
K152733 · Class 2 · Cardiovascular
Jan 2016
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.